Laurion Capital Management »

Xenon Pharmaceuticals shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.5M 75k 46.06
2022-06-30 $304k 10k 30.40

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf (HYG)
Meta Platforms Cl A Call Option (META)
Apple (AAPL)
Tesla Motors Call Option (TSLA)
Kenvue (KVUE)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Adobe Systems Incorporated Call Option (ADBE)
Alphabet Cap Stk Cl C Call Option (GOOG)
Bridgebio Pharma (BBIO)
NVIDIA Corporation Call Option (NVDA)
Bank of America Corporation (BAC)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Intel Corporation Call Option (INTC)

View all positions for Laurion Capital Management

Top funds holding Xenon Pharmaceuticals

venBio Select Advisor
Wellington Management Company
Commodore Capital
Paradigm Biocapital Advisors
Braidwell
First Light Asset Management
Alliancebernstein
Marshall Wace
Citadel Advisors
Perceptive Advisors
Baker Bros. Advisors
Henderson Group
BVF
Point72 Asset Management
Avidity Partners Management

View all funds holding Xenon Pharmaceuticals